Justin Anslow

Justin Anslow, an associate in Goodwin's Technology group and Capital Markets practice, represents public and late-stage companies and has significant experience in capital markets transactions. He represents companies, investment banks and investors in IPOs and follow-on public offerings, de-SPAC transactions, PIPE transactions, private placements (including Rule 144A debt offerings) and merger and acquisition transactions. Justin also advises clients across multiple industries on SEC reporting and disclosure obligations, stock exchange rules and regulations, and a broad range of corporate governance matters.

Justin provides ongoing corporate governance and securities law advice to many of the firm’s public company clients, including HubSpot, BJ’s Wholesale Club, IPG Photonics, Nerdy, Dynatrace, Altimmune, Yatra and Forge Global.

Justin's recent transactional experience includes:

• Represented Sam Altman and affiliated entities in connection with the IPO of Reddit
• Represented Arrowroot Capital Acquisition Corp. in its business combination with iLearningEngines
• Represented RA Capital as the lead investor in the $240 million private placement of Cidara Therapeutics
• Representing Lynk Global in its proposed business combination with SLAM Corp.
• Represented Goldman Sachs and J.P. Morgan as the representatives in the $300 million convertible senior notes offering by Rapid7
• Represented eMagin in its acquisition by Samsung Display Co.
• Represented Dynatrace, Inc. in connection with the sale of $500 million of shares by selling stockholders
• Represented Nerdy in its consent solicitation and exchange of outstanding public and private warrants
• Represented Toast in its $1 billion IPO
• Represented the Forbes Family in connection with multiple proposed sales of Forbes Global Media Holdings Inc.
• Represented WisdomTree in a strategic transaction and issuance of preferred stock
• Represented Frazier Life Sciences Acquisition Corp. in its business combination with NewAmsterdam Pharma Holding B.V.
• Represented Carbon Revolution in its business combination with Twin Ridge Capital Acquisition Corp.
• Represented Greenlight BioSciences in a $110 million PIPE transaction and in its subsequent take private transaction
• Represented Vivo Capital as the lead investor in the PIPE financings of Delcath Systems, Gracell BioTechnologies and Unicycive Therapeutics
• Represented RA Capital as the lead investor in the private placement of SAB Biotherapeutics
• Represented the underwriters in connection with the $237 million public offering by stockholders of KnowBe4
• Represented Forge Global, Inc. in its business combination with Motive Capital Corp.
• Represented Cano Health, Inc. in a $300 million of senior convertible notes and in connection with its entering into a $150 million term loan
• Represented the existing stockholders of Zapata AI, Wag!, Aurora Innovation and Vacasa in connection with the respective de-SPAC transactions of each company
• Represented LendingTree, Inc. in a $300 million convertible senior notes offering*
• Represented GAN Limited in its IPO and subsequent public offerings*
• Represented LKQ Corporation in a €1 billion senior notes offering*
• Represented Cardiff Oncology in a public offering of $100 million of shares*
• Represented BioXcel Therapeutics, Aridis Pharmaceuticals and Kiromic BioPharma in the IPOs of each company*
• Represented Tiziana Life Sciences in a follow-on public offering of $60 million of its American depositary shares*
• Represented investment banks in connection with underwritten, PIPE, registered direct and at-the-market offerings*
• Represented multiple SPACs in their IPOs including Goal Acquisitions Corp, Hennessy Capital Acquisition Corp. II and Global Partner Acquisition Corp.*

*Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Justin was an associate in the New York office of Sheppard, Mullin, Richter & Hampton LLP.

Justin has been recognized by The Best Lawyers in America as Ones to Watch for 2024.